Andrographolide promoted ferroptosis to repress the development of non-small cell lung cancer through activation of the mitochondrial dysfunction
- 11 December 2022
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 109, 154601
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81973810)
- Shanghai Shenkang Hospital Development Center (SHDC2020CR1052B)
This publication has 34 references indexed in Scilit:
- Pharmacological Aspects and Potential Use of Phloretin: A Systemic ReviewMini-Reviews in Medicinal Chemistry, 2019
- The development of the concept of ferroptosisFree Radical Biology and Medicine, 2019
- Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathwayJournal of Experimental & Clinical Cancer Research, 2018
- Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancerCancer Communications, 2018
- Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathwaysAutophagy, 2016
- Cytotoxicity and cell cycle arrest induced by andrographolide lead to programmed cell death of MDA-MB-231 breast cancer cell lineJournal of Biomedical Science, 2016
- Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cellsHepatology, 2015
- Andrographolide inhibits hypoxia-inducible factor-1 through phosphatidylinositol 3-kinase/AKT pathway and suppresses breast cancer growthOncoTargets and Therapy, 2015
- Inactivation of the Ferroptosis Regulator Gpx4 Triggers Acute Renal Failure in a Therapeutically Relevant MechanismFree Radical Biology and Medicine, 2014
- Chemopreventive and antioxidant efficacy of (6)-paradol in 7, 12-dimethylbenz(a)anthracene induced hamster buccal pouch carcinogenesisPharmacological Reports, 2010